Viewing Study NCT06132256


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
Study NCT ID: NCT06132256
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2023-11-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: Syndax Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module